Polaryx Therapeutics Statistics
Total Valuation
PLYX has a market cap or net worth of $266.54 million. The enterprise value is $261.87 million.
| Market Cap | 266.54M |
| Enterprise Value | 261.87M |
Important Dates
The next estimated earnings date is Friday, May 22, 2026, before market open.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PLYX has 47.34 million shares outstanding. The number of shares has increased by 32.81% in one year.
| Current Share Class | 47.34M |
| Shares Outstanding | 47.34M |
| Shares Change (YoY) | +32.81% |
| Shares Change (QoQ) | +2.36% |
| Owned by Insiders (%) | 32.02% |
| Owned by Institutions (%) | 3.90% |
| Float | 4.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 58.49 |
| P/TBV Ratio | 58.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.55
| Current Ratio | 8.55 |
| Quick Ratio | 8.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -193.70% and return on invested capital (ROIC) is -105.38%.
| Return on Equity (ROE) | -193.70% |
| Return on Assets (ROA) | -96.12% |
| Return on Invested Capital (ROIC) | -105.38% |
| Return on Capital Employed (ROCE) | -171.33% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$816,818 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.06 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.00 |
| Average Volume (20 Days) | 187,627 |
Short Selling Information
The latest short interest is 237,711, so 0.50% of the outstanding shares have been sold short.
| Short Interest | 237,711 |
| Short Previous Month | 393,306 |
| Short % of Shares Out | 0.50% |
| Short % of Float | 4.77% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.82M |
| Pretax Income | -8.99M |
| Net Income | -8.99M |
| EBITDA | n/a |
| EBIT | -7.82M |
| Earnings Per Share (EPS) | -$0.20 |
Balance Sheet
The company has $5.14 million in cash and n/a in debt, giving a net cash position of $5.14 million or $0.11 per share.
| Cash & Cash Equivalents | 5.14M |
| Total Debt | n/a |
| Net Cash | 5.14M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 4.57M |
| Book Value Per Share | 0.10 |
| Working Capital | 4.57M |
Cash Flow
| Operating Cash Flow | -3.94M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PLYX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.81% |
| Shareholder Yield | -32.81% |
| Earnings Yield | -3.36% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PLYX is $10.00, which is 77.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 77.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |